Trial Profile
A Randomized, Double-blinded, Placebo-controlled, and Multi-centered Clinical Trial Evaluating the Efficacy and Safety of Tacrolimus Capsule in Myasthenia Gravis That Was Insufficiently Treated by Glucocorticoid Therapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Apr 2015
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Myasthenia gravis
- Focus Registrational; Therapeutic Use
- Sponsors Astellas Pharma
- 26 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 31 Mar 2014 New trial record
- 10 Dec 2013